| 3/4/2019 |
2538U Loxapine, Urine |
| 2/25/2019 |
2458SP Isotretinoin and Metabolite, Serum/Plasma |
| 1/7/2019 |
2055B Ethylene Glycol Overexposure Profile, Blood |
| 1/7/2019 |
2134B Formic Acid, Blood |
| 1/7/2019 |
2837B Methanol Poisoning Profile, Blood |
| 11/15/2018 |
3752B Phosphatidylethanol, Blood |
| 10/1/2018 |
6110U Cadmium Exposure Profile (OSHA), Urine |
| 9/28/2018 |
0718SP Brivaracetam, Serum/Plasma |
| 9/28/2018 |
0718B Brivaracetam, Blood |
| 7/9/2018 |
9146U Ethyl Glucuronide Screen, Umbilical Cord Tissue |
| 4/12/2018 |
0413B Brodifacoum (Qualitative), Blood |
| 2/6/2018 |
0966SP Cannabis Plus Recent Use Markers, S/P |
| 2/6/2018 |
0966B Cannabis Plus Recent Use Markers, Blood |
| 1/3/2018 |
4283U Synthetic Cannabinoid Metabolites - Expanded, Urine (Qualitative) |
| 11/14/2017 |
1487B Methoxyacetyl fentanyl, cis/trans 3-Methylfentanyl, Cyclopropyl fentanyl (Quantitative Forensic Investigation), Blood |
| 11/4/2017 |
0716SP Brexpiprazole, Serum/Plasma |
| 6/24/2017 |
3427SP Perfluoroalkyl Substances (PFAS), Serum/Plasma |
| 6/14/2017 |
1480U Designer Opioids (2017 Scope) (Qualitative) |
| 6/13/2017 |
0965SP Recent Cannabis Use Markers, S/P |
| 6/13/2017 |
0965B Recent Cannabis Use Markers, Blood |
| 6/7/2017 |
8062TI Postmortem, Expanded, Tissue (Forensic) |
| 6/7/2017 |
8062FL Postmortem, Expanded, Fluid (Forensic) |
| 5/12/2017 |
0570U Designer Benzodiazepines, Urine |
| 2/27/2017 |
4282SP Synthetic Cannabinoids (Qualitative) (2017 Scope), Serum/Plasma |
| 1/20/2017 |
1480SP Designer Opioids (2017 Scope), Srm/Plsma |
| 1/20/2017 |
1480B Designer Opioids (2017 Scope), Blood |
| 1/6/2017 |
9351UC Basic Drug Screen, Umbilical Cord Tissue |
| 1/6/2017 |
9352UC Expanded Drug Screen, Umbilical Cord Tissue |
| 12/14/2016 |
3245U Organophosphate Pesticide Metabolites, Urine |
| 10/27/2016 |
1486SP Carfentanil, Furanyl Fentanyl, and U-47700 (Quantitative Forensic Investigation), Serum/Plasma |
| 10/27/2016 |
1486B Carfentanil, Furanyl Fentanyl, and U-47700 (Quantitative Forensic Investigation), Blood |
| 10/14/2016 |
3064SP Mitragynine, Serum/Plasma |
| 10/14/2016 |
3064B Mitragynine, Blood |
| 10/10/2016 |
8098SP Drug Screen (GC/MS), Serum/Plasma |
| 10/4/2016 |
0570SP Designer Benzodiazepines, S/P (Forensic) |
| 10/4/2016 |
0570B Designer Benzodiazepines, Bld (Forensic) |
| 8/31/2016 |
8054B Postmortem, Expanded w/NPS, Blood (Forensic) |
| 8/27/2016 |
2533SP Loperamide and Metabolite, S/P |
| 8/27/2016 |
2533B Loperamide and Metabolite, Blood |
| 6/28/2016 |
9145UC Comprehensive Drug Screen, Umbilical Cord Tissue |
| 5/26/2016 |
2457SP Isavuconazole, Serum/Plasma |
| 4/1/2016 |
0939B Calcium - Total, Blood (Forensic) |
| 2/11/2016 |
6605S Borrelia burgdorferi total Ab by ELISA with reflex to IgG by Western Blot (Late Disease) |
| 2/11/2016 |
6604S Borrelia burgdorferi total Ab by ELISA with reflex to IgG and IgM by Western Blot (Early Disease) |
| 2/11/2016 |
6602S Borrelia burgdorferi Antibody, IgM by Western Blot, Serum |
| 2/11/2016 |
6603S Borrelia burgdorferi Antibody, IgG and IgM by Western Blot, Serum |
| 2/11/2016 |
6600S Borrelia burgdorferi Antibodies, Total by ELISA, Serum |
| 2/11/2016 |
6601S Borrelia burgdorferi Antibody, IgG by Western Blot, Serum |
| 11/12/2015 |
7177SL Quantitation of THC, THCA, CBD and CBN in Botanical Material by HPLC-DAD, Solid |
| 8/25/2015 |
4127ME Suboxone® - Total (Qualitative), Meconium |
| 8/25/2015 |
9206U Dextrorphan / Levorphanol Screen - Total, U |
| 8/20/2015 |
4236B Suvorexant, Blood |
| 8/20/2015 |
4236SP Suvorexant, Serum/Plasma |
| 8/19/2015 |
2500SP Leptin, Serum/Plasma |
| 8/17/2015 |
1021U Substituted Cathinone Panel, Urine |
| 8/17/2015 |
1021B Substituted Cathinone Panel, Blood |
| 8/17/2015 |
1021SP Substituted Cathinone Panel, S/P |
| 7/22/2015 |
3371SP PCB Panel, Congeners, Serum/Plasma |
| 7/14/2015 |
7658SP Cortisone, Serum/Plasma |
| 7/14/2015 |
7659SP Cortisol and Cortisone, Serum/Plasma |
| 6/10/2015 |
8210SP Novel Psychoactive Substances Expanded |
| 6/10/2015 |
8210U Novel Psychoactive Substances Expanded |
| 6/10/2015 |
8210B Novel Psychoactive Substances Expanded |
| 6/10/2015 |
1485B Designer Opioids, Blood |
| 6/10/2015 |
1485SP Designer Opioids, Serum/Plasma |
| 5/8/2015 |
4489SP Tofacitinib, Serum/Plasma |
| 5/8/2015 |
4489B Tofacitinib, Blood |
| 2/4/2015 |
4102SP Rosiglitazone, Serum/Plasma |
| 2/4/2015 |
4101SP Repaglinide, Serum/Plasma |
| 2/4/2015 |
4102B Rosiglitazone, Blood |
| 2/4/2015 |
4101B Repaglinide, Blood |
| 2/4/2015 |
3779SP Pioglitazone, Serum/Plasma |
| 2/4/2015 |
3118B Nateglinide, Blood |
| 2/4/2015 |
3118SP Nateglinide, Serum/Plasma |
| 2/4/2015 |
3779B Pioglitazone, Blood |
| 2/4/2015 |
2159B Glimepiride, Blood |
| 2/4/2015 |
2159SP Glimepiride, Serum/Plasma |
| 1/30/2015 |
3325B Paraquat, Blood |
| 1/30/2015 |
1789B Diquat, Blood |
| 1/30/2015 |
1789SP Diquat, Serum/Plasma |
| 1/24/2015 |
7365SL DNA Analysis, Data Pack |
| 12/5/2014 |
7679S Dihydrotestosterone (DHT), Serum |
| 11/7/2014 |
7311SL DNA Analysis, RapidHIT GlobalFiler Express |
| 10/14/2014 |
0430U Aromatic Solvents Metabolites Panel 2, Urine |
| 10/10/2014 |
1876FL Drug Screen - Expanded, Fluid |
| 10/10/2014 |
1876SP Drug Screen - Expanded, Serum/Plasma |
| 7/16/2014 |
7360SL DNA Analysis, Y-STR (Databasing/Property Crime) |
| 7/16/2014 |
7361SL Legal Paternity Testing (STR Analysis) |
| 7/16/2014 |
7358SL Kinship Analysis (STR Analysis |
| 7/16/2014 |
7359 DNA Analysis, Autosomal STR (Databasing/Property Crime) |
| 7/16/2014 |
7357SL DNA Analysis, Y-STR (Reference) |
| 7/16/2014 |
7356SL DNA Analysis, Minifiler (Casework |
| 7/16/2014 |
8150B ProofPOSITIVE® Drug Impaired Driving/DRE Toxicology Panel |
| 7/16/2014 |
8151B ProofPOSITIVE® Drug Impaired Driving/DRE ToxicologyPanel (with Alcohol) |
| 6/26/2014 |
4047SP Pyrrolidinophenone Panel, Serum/Plasma |
| 6/26/2014 |
4046SP Pyrrolidinophenone Panel (Qualitative), S/P |
| 6/26/2014 |
4047B Pyrrolidinophenone Panel, Blood |
| 6/26/2014 |
4046B Pyrrolidinophenone Panel (Qualitative), Bld |
| 6/14/2014 |
7678P Plasma Renin Activity, Plasma |
| 5/28/2014 |
7679S Dihydrotestosterone (DHT), Serum |
| 5/9/2014 |
2428SP Iodine, Serum/Plasma |
| 5/9/2014 |
2428U Iodine - Total, Urine |
| 4/24/2014 |
4791SP Vortioxetine, Serum/Plasma |
| 3/29/2014 |
3143B NBOMe (Qualitative), Blood |
| 3/29/2014 |
3143SP NBOMe (Qualitative), Serum/Plasma |
| 2/22/2014 |
4367 Teriflunomide (Pre-Pregnancy Monitoring) |
| 2/22/2014 |
4366 Teriflunomide (Therapeutic Drug Monitoring) |
| 2/22/2014 |
2531 Leflunomide as Metabolite (Therapeutic Drug Monitoring) |
| 2/22/2014 |
2532 Leflunomide as Metabolite (Pre-Pregnancy Monitoring) |
| 2/11/2014 |
3143U NBOMe (Qualitative), Urine |
| 1/21/2014 |
7676P Norepinephrine - Free, Plasma |
| 1/21/2014 |
7677P Catecholamines, Fractionated & Free |
| 1/21/2014 |
7673P Catecholamines, Fractionated & Free |
| 1/21/2014 |
7674P Dopamine - Free, Plasma |
| 1/21/2014 |
7675P Epinephrine - Free, Plasma |
| 1/8/2014 |
0775B Budesonide, Serum/Plasma |
| 10/16/2013 |
1290UH Cobalt, 24 Hour Urine |
| 10/4/2013 |
9190B Ketoacidosis Screen, Blood |
| 10/4/2013 |
9190FL Ketoacidosis Screen, Fluid |
| 10/3/2013 |
7079B Oxycodone Metabolizer Status, Blood |
| 10/3/2013 |
7077B Codeine Metabolizer Status, Blood |
| 10/3/2013 |
7078B Tramadol Metabolizer Status, Blood |
| 8/30/2013 |
2665B Mercaptopurine and Metabolites, Blood |
| 8/13/2013 |
9568U Synthetic Cannabinoid Metabolites Screen 2, Urine |
| 7/31/2013 |
4519TI Topiramate, Tissue |
| 7/31/2013 |
4125B Rufinamide, Blood |
| 7/31/2013 |
4519FL Topiramate, Fluid |
| 7/23/2013 |
2022SP Eplerenone, Serum/Plasma |
| 7/19/2013 |
0205U Acetyl Fentanyl, Urine |
| 7/19/2013 |
0205SP Acetyl Fentanyl, Serum/Plasma |
| 7/19/2013 |
0205B Acetyl Fentanyl, Blood |
| 7/19/2013 |
8088B Qsymia®, Blood |
| 7/19/2013 |
8088SP Qsymia®, Serum/Plasma |
| 7/13/2013 |
9105SP Acetyl Fentanyl Screen, Serum/Plasma |
| 7/13/2013 |
9105U Acetyl Fentanyl Screen, Urine |
| 7/13/2013 |
0505SP Bedaquiline, Serum/Plasma |
| 7/13/2013 |
9105B Acetyl Fentanyl Screen, Blood |
| 7/2/2013 |
9005OF Drug Impaired Driving/DRE Toxicology Panel (Qualitative), Oral Fluid |
| 6/11/2013 |
0245U Alpha PVP, Urine |
| 6/11/2013 |
0245SP Alpha PVP, Serum/Plasma |
| 6/11/2013 |
0245B Alpha PVP, Blood |
| 5/18/2013 |
0448SP Apixaban, Serum/Plasma |
| 5/18/2013 |
4114SP Rivaroxaban, Serum/Plasma |
| 5/16/2013 |
0078SP 5-Fluorouracil and Metabolite, S/P |
| 5/1/2013 |
0110SP 1,25-Dihydroxyvitamin D, Serum/Plasma |
| 4/24/2013 |
3135SP Vitamin K, Serum/Plasma |
| 3/21/2013 |
1515B Diazoxide, Blood |
| 3/21/2013 |
1495SP Desomorphine, Serum/Plasma |
| 3/21/2013 |
2345B Hydroflumethiazide, Blood |
| 3/21/2013 |
1495B Desomorphine, Blood |
| 3/19/2013 |
0495SP Avanafil, Serum/Plasma |
| 3/19/2013 |
0495B Avanafil, Blood |
| 3/5/2013 |
0420FL Betahydroxybutyric Acid, Fluid |
| 3/5/2013 |
0420B Betahydroxybutyric Acid, Blood |
| 2/18/2013 |
4525B Torsemide, Blood |
| 2/18/2013 |
4525SP Torsemide, Serum/Plasma |
| 2/18/2013 |
4624U Trichloroacetic Acid, Urine |
| 2/14/2013 |
2397SP Indapamide, Serum/Plasma |
| 2/8/2013 |
3433SP Perampanel, Serum/Plasma |
| 1/24/2013 |
9318U Diuretics Screen, Urine |
| 1/4/2013 |
9235SP Phenazepam Screen (Qualitative), S/P |
| 1/4/2013 |
9235U Phenazepam Screen (Qualitative), Urine |
| 1/4/2013 |
9229SP DMAA Screen, Serum/Plasma |
| 1/4/2013 |
9235B Phenazepam Screen (Qualitative), Blood |
| 1/4/2013 |
9229B DMAA Screen, Blood |
| 1/4/2013 |
9229U DMAA Screen, Urine |
| 1/4/2013 |
0278SP DMAA, Serum/Plasma |
| 1/4/2013 |
0278B DMAA, Blood |
| 1/4/2013 |
0278U DMAA, Urine |
| 1/4/2013 |
4365SP Teriflunomide, Serum/Plasma |
| 1/4/2013 |
4365U Teriflunomide, Urine |
| 1/4/2013 |
4365B Teriflunomide, Blood |
| 12/28/2012 |
4029SP Psilocybin as Psilocin (Qualitative), S/P |
| 12/28/2012 |
4029B Psilocybin as Psilocin (Qualitative), Blood |
| 12/28/2012 |
4029U Psilocybin as Psilocin (Qualitative), Urine |
| 1/1/2012 |
8898OF Drugs of Abuse (6 Panel) (Qualitative), Oral Fluid |
| 1/1/2012 |
9570U Tapentadol Screen, Urine |
| 1/1/2012 |
8085U Drug Impaired Driving/DRE Bath Salts Add-On, Urine |
| 1/1/2012 |
8085SP Drug Impaired Driving/DRE Bath Salts Add-On, S/P |
| 1/1/2012 |
8065TI Bath Salts Screen (Forensic), Tissue |
| 1/1/2012 |
8085B Drug Impaired Driving/DRE Bath Salts Add-On, Blood |
| 1/1/2012 |
8065SP Bath Salts Screen (Forensic), Serum/Plasma |
| 1/1/2012 |
8065FL Bath Salts Screen (Forensic), Fluid |
| 1/1/2012 |
8065U Bath Salts Screen (Forensic), Urine |
| 1/1/2012 |
2626SP Bath Salts Panel, Serum/Plasma |
| 1/1/2012 |
8065B Bath Salts Screen (Forensic), Blood |
| 1/1/2012 |
2626B Bath Salts Panel, Blood |
| 1/1/2012 |
7308SL DNA Analysis, Full Profile (Reference) |
| 1/1/2012 |
1876B Drug Screen, Expanded, Blood |
| 1/1/2012 |
1876U Drug Screen, Expanded, Urine |
| 1/1/2012 |
1874U Drug Screen (9 Panel), Urine |
| 1/1/2012 |
2092B Fluoride Preservative Determination, Blood |
| 1/1/2012 |
1874B Drug Screen (9 Panel), Blood |
| 1/1/2012 |
9567OF Synthetic Cannabinoids (qualitative), Oral Fluid |
| 1/1/2012 |
1935SP Exemestane, Serum/Plasma |
| 1/1/2012 |
4025SP Ezogabine and Metabolite, Serum/Plasma |
| 1/1/2012 |
2478U Zolpidem and Metabolites, Urine |
| 1/1/2012 |
9564U Synthetic Cannabinoid Metabolites Screen - Basic |
| 1/1/2012 |
4155B Sativex®, Blood |
| 1/1/2012 |
4155SP Sativex®, Serum/Plasma |
| 1/1/2012 |
1902B Duexis®, Blood |
| 1/1/2012 |
1902SP Duexis®, Serum/Plasma |
| 1/1/2012 |
2527FL Lacosamide, Fluid |
| 1/1/2012 |
2479U Ketamine and Metabolite, Urine |
| 1/1/2012 |
8756SP Bath Salts & Stimulants Designer Drugs-Expanded |
| 1/1/2012 |
8061TI Postmortem Toxicology-Basic, w/o Alcohol, Tissue |
| 1/1/2012 |
8756U Bath Salts & Stimulants Designer Drugs-Expanded |
| 1/1/2012 |
8756B Bath Salts & Stimulants Designer Drugs-Expanded |
| 1/1/2012 |
3078U Mitragynine and Metabolite (Qualitative), Urine |
| 1/1/2012 |
1348FL Creatinine (Vitreous), Fluid (Forensic) |
| 1/1/2012 |
0751SP Bromocriptine, Serum/Plasma |
| 1/1/2012 |
7309SL Post-PCR Cleanup Analysis |